IVC Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Buy
1,341
+2
+0.1% +$2.04K 0.63% 32
2026
Q1
$1.23M Sell
1,339
-92
-6% -$93.3K 0.53% 35
2025
Q4
$1.54M Buy
1,431
+20
+1% +$19.1K 0.67% 27
2025
Q3
$1.08M Sell
1,411
-52
-4% -$38.7K 0.48% 43
2025
Q2
$1.14M Buy
1,463
+29
+2% +$22.5K 0.56% 39
2025
Q1
$1.18M Buy
1,434
+16
+1% +$13.3K 0.64% 35
2024
Q4
$1.09M Sell
1,418
-94
-6% -$77.8K 0.61% 36
2024
Q3
$1.34M Sell
1,512
-311
-17% -$280K 0.73% 33
2024
Q2
$1.65M Sell
1,823
-422
-19% -$338K 0.92% 22
2024
Q1
$1.75M Sell
2,245
-60
-3% -$42.7K 1.01% 19
2023
Q4
$1.34M Sell
2,305
-95
-4% -$55.5K 0.84% 27
2023
Q3
$1.29M Sell
2,400
-533
-18% -$275K 0.86% 26
2023
Q2
$1.38M Sell
2,933
-57
-2% -$23.9K 0.87% 26
2023
Q1
$1.03M Sell
2,990
-5
-0.2% -$1.69K 0.73% 32
2022
Q4
$1.1M Sell
2,995
-5
-0.2% -$1.77K 0.81% 29
2022
Q3
$970K Buy
3,000
+9
+0.3% +$2.85K 0.78% 32
2022
Q2
$970K Sell
2,991
-237
-7% -$71.1K 0.75% 36
2022
Q1
$924K Buy
3,228
+170
+6% +$43.8K 0.61% 43
2021
Q4
$845K Sell
3,058
-435
-12% -$110K 0.54% 48
2021
Q3
$807K Sell
3,493
-150
-4% -$37K 0.56% 51
2021
Q2
$836K Sell
3,643
-5
-0.1% -$1K 0.59% 48
2021
Q1
$682K Buy
3,648
+100
+3% +$19.6K 0.54% 51
2020
Q4
$599K Buy
+3,548
New +$530K 0.57% 52

Other funds holding LLY

IVC Wealth Advisors's LLY Position: Q2 2026 in Review

IVC Wealth Advisors increased its Eli Lilly (LLY) stake by 0.15% in Q2 2026, buying an estimated $2.04K and bringing the position to 1,341 shares worth $1.61M. The position accounts for 0.63% of the portfolio, ranked #32.

IVC Wealth Advisors first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.75M in Q1 2024. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • IVC Wealth Advisors held 1,341 shares of Eli Lilly worth $1.61M as of Q2 2026.
  • IVC Wealth Advisors bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.63% of IVC Wealth Advisors's portfolio in Q2 2026, its #32 holding.
  • IVC Wealth Advisors first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • IVC Wealth Advisors's Eli Lilly position peaked at $1.75M in Q1 2024.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on IVC Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.